Clusterin (or ApoJ) is an apolipoprotein that is genetically associated with AD and might play a pathogenic role in AD through effects on Aβ aggregation or other mechanisms, e.g. by immune system influence or by disrupting healing after neurodegeneration, and isoforms of clusterin has been suggested as a promising biomarkers in AD14,15. Here, CLU is linked to Alzheimer disease.